LAS100977, A Novel Beta-2 Receptor Agonist, With A Longer Duration Of Action And More Favourable Safety Margin Than Salmeterol In Anesthetised Dogs
暂无分享,去创建一个
J. Beleta | H. Ryder | J. Gras | J. Llenas | M. Miralpeix | M. Gómez-Angelats | M. Aparici | C. Puig | A. Gavaldà | M. Viñals